4.6 Article

Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations

Jonathan D. Ravid et al.

Summary: SARS-CoV-2 infection leads to severe blood clot formation causing organ failure and death. Besides the cytokine storm, disruptions in platelets, endothelial cells, and the coagulation system play a crucial role in triggering systemic coagulopathy. Activated Janus kinase (JAK) signaling has been implicated in enhancing thrombotic processes and organ dysfunction. However, the potential therapeutic applications of JAK inhibitors for treating the inflammation-thrombosis phenotype in COVID-19 patients remain controversial.
Article Chemistry, Multidisciplinary

The NKT cell TCR repertoire can accommodate structural modifications to the lipid and orientation of the terminal carbohydrate of iGb3

Garth Cameron et al.

Summary: This study reports a new type of isoglobotrihexosylceramide (iGb3) and four iGb3 analogues on the immunological activity of NKT cells. The results indicate that the conformation of the terminal sugar residue is not essential for NKT cell TCR recognition, and the NKT cell TCR can accommodate variations in iGb3-based glycolipids.

RSC ADVANCES (2022)

Article Cardiac & Cardiovascular Systems

Pannexin 1 channels control the hemodynamic response to hypoxia by regulating O2-sensitive extracellular ATP in blood

Brett S. Kirby et al.

Summary: The study found that Panx1 channels participate in hypoxic vasodilation by regulating hypoxia-sensitive extracellular ATP levels in blood. Mice lacking Panx1 showed attenuated decrease in blood pressure and reduced increase in limb blood flow during hypoxia, along with lower plasma ATP levels. This indicates the important role of Panx1 in vascular responses to hypoxia.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2021)

Article Allergy

Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study

Giorgio Bozzi et al.

Summary: The study involving 120 COVID-19 patients showed that treatment with anakinra plus methylprednisolone could reduce the risk of death, especially in patients with hyperinflammation and respiratory failure. Randomized controlled trials are needed to confirm these findings.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Medicine, General & Internal

IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical Finding

Sofija Sekulic Markovic et al.

Summary: The study highlights the significant correlation of increased IL-33 with disease severity in COVID-19 patients, especially in the advanced stage, where IL-33 facilitates lung inflammation by inducing proinflammatory cytokines. IL-33 may serve as a promising marker and therapeutic target in COVID-19.

FRONTIERS IN MEDICINE (2021)

Review Immunology

A hitchhiker's guide through the COVID-19 galaxy

Susanna Felsenstein et al.

Summary: This review aims to combine current knowledge of the immunopathology of COVID-19 with evidence of available treatment options to provide frontline healthcare workers with an understanding of host response in COVID-19 patients and support their efforts in selecting tailored treatment options for their patients.

CLINICAL IMMUNOLOGY (2021)

Review Environmental Sciences

Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic

Naim Mahroum et al.

Summary: Tocilizumab shows potential efficacy in severe COVID-19, especially in reducing mortality rates and preventing ICU admissions, according to a systematic review and meta-analysis. However, the risk of infection may increase when combined with corticosteroid therapy.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Pharmacology & Pharmacy

Case Report: Can Inhaled Adenosine Attenuate COVID-19?

Bruce D. Spiess et al.

Summary: This case report involves two patients in the United States who were expected to die but showed positive response to inhaled adenosine treatment, supporting its role as a therapeutic nucleoside.

FRONTIERS IN PHARMACOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Adenosine A2A receptor agonist (regadenoson) in human lung transplantation

Christine L. Lau et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)

Article Microbiology

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis

Shi-Hui Sun et al.

CELL HOST & MICROBE (2020)

Article Medicine, Research & Experimental

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Public, Environmental & Occupational Health

Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection

Gregory Brett Moreau et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)

Article Immunology

Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients

Youenn Jouan et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Review Hematology

D-dimer level in COVID-19 infection: a systematic review

Mehrdad Rostami et al.

EXPERT REVIEW OF HEMATOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Unmasking Adenosine: The Purinergic Signalling Molecule Critical to Arrhythmia Pathophysiology and Management

Gareth D. K. Matthews et al.

ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW (2019)

Article Cardiac & Cardiovascular Systems

Safety of regadenoson stress testing in patients with pulmonary hypertension

Victor M. Moles et al.

JOURNAL OF NUCLEAR CARDIOLOGY (2018)

Article Medicine, Research & Experimental

Glucocorticoid attenuates acute lung injury through induction of type 2 macrophage

Guo-wei Tu et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2017)

Article Immunology

mTORC2 regulates multiple aspects of NKT-cell development and function

Tammarah Sklarz et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2017)

Review Immunology

Purinergic regulation of the immune system

Caglar Cekic et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Article Biochemistry & Molecular Biology

Adenosine A2A receptor, a potential valuable target for controlling reoxygenated DCs-triggered inflammation

Chunmei Liu et al.

MOLECULAR IMMUNOLOGY (2015)

Article Biochemistry & Molecular Biology

Pannexin 1, an ATP Release Channel, Is Activated by Caspase Cleavage of Its Pore-associated C-terminal Autoinhibitory Region

Joanna K. Sandilos et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Hematology

P-Selectin-Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease

Renata Polanowska-Grabowska et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)

Article Hematology

Central role of Sp1-regulated CD39 in hypoxia/ischemia protection

Holger K. Eltzschig et al.